A Practical Guide to Producing and Maintaining the Pharmacovigilance System Master File (PSMF) Training Course (VIRTUAL EVENT: Feb 13, 2026) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “A Practical Guide to Producing and Maintaining the PSMF Training Course (Feb 13, 2026)” training has been added... Read more.
The Patent Administrator Training Course: Demystify Procedures and Filing Requirements in Key Jurisdictions, and Improve Your Knowledge and Skills (Feb 10, 2026) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “The Patent Administrator Training Course (Feb 10, 2026)” training has been added to ResearchAndMarkets.com’s... Read more.
Under the Patronage of Hamdan bin Zayed 2025 Abu Dhabi Maritime Awards Winners Set New Standards for the Marina Industry
The third edition of the Awards celebrated marina excellence across the MENAT region 2025 marked the introduction of artificial intelligence as a supportive tool... Read more.
SemiLEDs Reports Fourth Quarter and Fiscal Year End 2025 Financial Results
HSINCHU, Taiwan–(BUSINESS WIRE)–SemiLEDs Corporation (NASDAQ: LEDS), “SemiLEDs” or the “Company,” a developer and manufacturer of LED chips and... Read more.
Number of Shares and Voting Rights of Innate Pharma as of November 27, 2025
MARSEILLE, France–(BUSINESS WIRE)–Regulatory News: Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of... Read more.
VSO Unveils VCP v1.0, a First-of-Its-Kind Cryptographic Audit Protocol to Restore Trust in AI-Driven Markets
New open standard replaces opaque server logs with mathematically verifiable evidence, helping market participants meet EU AI Act and MiFID II transparency requirements... Read more.
Omdia: Mainland China’s Cloud Infrastructure Market Returns to Over 20% Growth in Q2 2025
LONDON–(BUSINESS WIRE)–#AI–According to Omdia, mainland China’s cloud infrastructure services market reached $12.4 billion in Q2 2025, up 21%... Read more.
Celltrion receives Health Canada approval for Eydenzelt®, a biosimilar referencing Eylea® (aflibercept 2mg)
Eydenzelt® a biosimilar referencing Eylea®, receives a Notice of Compliance from Health Canada (aflibercept 2mg) The approval is based on the totality of evidence,... Read more.
Dentalcorp Announces that Leading Proxy Advisors ISS and Glass Lewis Recommend Dentalcorp Shareholders Vote “FOR” the Arrangement and Provides Update Regarding Partner Dentist Rollover Opportunity
Securityholders are encouraged to vote “FOR” the special resolution approving the Arrangement in advance of the December 2, 2025 at 11:00 a.m. (Toronto time)... Read more.
Dream Impact Trust Announces Correction to Voting Results of Special Meeting of Unitholders
TORONTO–(BUSINESS WIRE)–DREAM IMPACT TRUST (TSX: MPCT.UN) (“Dream Impact” or the “Trust”), announced today that, at its special meeting (the... Read more.